• Login
    View Item 
    •   Repository Home
    • Research Journal Articles
    • Department of Basic Sciences
    • View Item
    •   Repository Home
    • Research Journal Articles
    • Department of Basic Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Development of Dimethylisoxazole-Attached Imidazo[1,2‑a]pyridines as Potent and Selective CBP/P300 Inhibitors

    Thumbnail
    View/Open
    Muthengi et al. J. Med. Ch em. 2021, 64, 5787−5801.pdf (3.986Mb)
    Date
    2021
    Author
    Muthengi, Alex
    Wimalasena, Virangika K.
    Yosief, Hailemichael O.
    Bikowitz, Melissa J.
    Sigua, Logan H.
    Wang, Tingjian
    Li, Deyao
    Zhang, Wei
    Qi, Jun
    Schönbrunn, Ernst
    Amaro, Rommie E.
    Erickson, Jon
    Liu, Shuai
    Dhawan, Gagan
    Gaieb, Zied
    Metadata
    Show full item record
    Abstract
    The use of epigenetic bromodomain inhibitors as anticancer therapeutics has transitioned from targeting bromodo main extraterminal domain (BET) proteins into targeting non-BET bromodomains. The two most relevant non-BET bromodomain oncology targets are cyclic AMP response element-binding protein (CBP) and E1A binding protein P300 (EP300). To explore the growing CBP/EP300 interest, we developed a highly efficient two step synthetic route for dimethylisoxazole-attached imidazo[1,2- a]pyridine scaffold-containing inhibitors. Our efficient two-step reactions enabled high-throughput synthesis of compounds designed by molecular modeling, which together with structure− activity relationship (SAR) studies facilitated an overarching understanding of selective targeting of CBP/EP300 over non BET bromodomains. This led to the identification of a new potent and selective CBP/EP300 bromodomain inhibitor, UMB298 (compound 23, CBP IC50 72 nM and bromodomain 4, BRD4 IC50 5193 nM). The SAR we established is in good agreement with literature-reported CBP inhibitors, such as CBP30, and demonstrates the advantage of utilizing our two-step approach for inhibitor development of other bromodomains.
    URI
    http://repository.tharaka.ac.ke/xmlui/handle/1/3170
    Collections
    • Department of Basic Sciences [70]

    Tharaka University copyright © 2020  Repository
    Contact Us | Send Feedback
    Designed by
    TUN Library
     

    TUN
     

     

    Browse

    All of RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Tharaka University copyright © 2020  Repository
    Contact Us | Send Feedback
    Designed by
    TUN Library
     

    TUN